Followers | 18 |
Posts | 919 |
Boards Moderated | 0 |
Alias Born | 04/28/2018 |

Monday, July 29, 2024 2:09:52 PM
Recent NVCR News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2025 08:26:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2025 08:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2025 08:19:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2025 08:16:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/06/2025 08:10:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 08:26:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 08:23:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 08:16:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2025 08:09:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/02/2025 08:25:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/02/2025 10:05:55 AM
- Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting • Business Wire • 05/31/2025 12:00:00 PM
- Novocure Announces Upcoming Investor Events • Business Wire • 05/27/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:17:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/05/2025 08:05:10 PM
- Optune Lua® di Novocure riceve l'approvazione del marchio CE per il trattamento del carcinoma polmonare non a piccole cellule (NSCLC) metastatico • Business Wire • 04/28/2025 08:00:00 AM
- Optune Lua® de Novocure reçoit l'approbation du marquage CE pour le traitement du cancer du poumon non à petites cellules métastatique • Business Wire • 04/28/2025 08:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/24/2025 11:02:25 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/24/2025 11:01:39 AM
- Novocure Reports First Quarter 2025 Financial Results • Business Wire • 04/24/2025 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/24/2025 12:00:46 AM
- Novocure to Present Results from the Phase 3 PANOVA-3 Clinical Trial of its Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer as a Late-Breaking Oral Presentation at the 2025 ASCO Annual Meeting • Business Wire • 04/23/2025 02:16:00 PM
- Optune Lua® von Novocure erhält CE-Kennzeichnung für die Behandlung von metastasierendem nicht-kleinzelligem Lungenkrebs (mNSCLC) • Business Wire • 04/23/2025 01:27:00 PM
- Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer • Business Wire • 04/22/2025 11:09:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2025 11:00:26 AM
Authentic Holdings Inc. Partnership with Swerve TV Debuts with Highly Successful 'Ring of Combat' Live Broadcast • AHRO • Jun 18, 2025 12:45 PM
ePIC Blockchain Signs LOI with A.R.T. Digital to Redefine Bitcoin Miner Design with Breakthrough Air-Cooling Technology • CGAC • Jun 18, 2025 12:41 PM
Avant Technologies' JV Partner, Ainnova, Begins Diabetic Retinopathy Screenings with Leading Pharmacies • AVAI • Jun 17, 2025 8:00 AM
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis • BLO • Jun 17, 2025 8:00 AM
A.R.T. Digital Holdings (OTC: CGAC) Secures Non-Dilutive Financing for George West Site Supporting NASDAQ: BTBT • CGAC • Jun 17, 2025 5:07 AM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM